Hainan Shuangcheng Pharmaceut (002693) - Total Liabilities
Based on the latest financial reports, Hainan Shuangcheng Pharmaceut (002693) has total liabilities worth CN¥393.42 Million CNY (≈ $57.57 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 002693 operating cash flow to assess how effectively this company generates cash.
Hainan Shuangcheng Pharmaceut - Total Liabilities Trend (2009–2024)
This chart illustrates how Hainan Shuangcheng Pharmaceut's total liabilities have evolved over time, based on quarterly financial data. Check 002693 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Hainan Shuangcheng Pharmaceut Competitors by Total Liabilities
The table below lists competitors of Hainan Shuangcheng Pharmaceut ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Yantai Longyuan Power Tech
SHE:300105
|
China | CN¥793.67 Million |
|
Zhejiang Tiantai Xianghe Industrial Co Ltd
SHG:603500
|
China | CN¥462.08 Million |
|
Jana Small Finance Bank
NSE:JSFB
|
India | Rs389.97 Billion |
|
Jiangsu Rutong Petro-Machinery
SHG:603036
|
China | CN¥164.64 Million |
|
Anhui Xinbo Aluminum Co Ltd
SHE:003038
|
China | CN¥8.06 Billion |
|
Nanjing Railway New Technology Co.Ltd.
SHE:301016
|
China | CN¥155.16 Million |
|
Hefei Gocom Information Technology Co Ltd
SHG:688367
|
China | CN¥144.72 Million |
|
Beijing Haohan Data Technology Co. Ltd. A
SHG:688292
|
China | CN¥474.86 Million |
Liability Composition Analysis (2009–2024)
This chart breaks down Hainan Shuangcheng Pharmaceut's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Hainan Shuangcheng Pharmaceut.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.86 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.49 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Hainan Shuangcheng Pharmaceut's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Hainan Shuangcheng Pharmaceut (2009–2024)
The table below shows the annual total liabilities of Hainan Shuangcheng Pharmaceut from 2009 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥372.26 Million ≈ $54.47 Million |
+30.34% |
| 2023-12-31 | CN¥285.60 Million ≈ $41.79 Million |
-13.47% |
| 2022-12-31 | CN¥330.08 Million ≈ $48.30 Million |
+14.69% |
| 2021-12-31 | CN¥287.80 Million ≈ $42.11 Million |
-6.97% |
| 2020-12-31 | CN¥309.37 Million ≈ $45.27 Million |
+13.44% |
| 2019-12-31 | CN¥272.72 Million ≈ $39.91 Million |
-39.47% |
| 2018-12-31 | CN¥450.56 Million ≈ $65.93 Million |
-26.79% |
| 2017-12-31 | CN¥615.41 Million ≈ $90.05 Million |
+0.49% |
| 2016-12-31 | CN¥612.40 Million ≈ $89.61 Million |
-1.63% |
| 2015-12-31 | CN¥622.56 Million ≈ $91.10 Million |
+1145.41% |
| 2014-12-31 | CN¥49.99 Million ≈ $7.31 Million |
+7.68% |
| 2013-12-31 | CN¥46.42 Million ≈ $6.79 Million |
+13.78% |
| 2012-12-31 | CN¥40.80 Million ≈ $5.97 Million |
+105.79% |
| 2011-12-31 | CN¥19.83 Million ≈ $2.90 Million |
-79.11% |
| 2010-12-31 | CN¥94.92 Million ≈ $13.89 Million |
+376.80% |
| 2009-12-31 | CN¥19.91 Million ≈ $2.91 Million |
-- |
About Hainan Shuangcheng Pharmaceut
Hainan Shuangcheng Pharmaceuticals Co., Ltd. provides peptide, lyophilized, oncology, oral dosage, and other injection cartridge pharmaceutical products worldwide. The company offers thymalfasin, thymapentin, bortezmib, paclitaxel, somatostatin, pantoprazole, epifibatide, bivalirudin, liraglutide, and exenatide and sodium ferulate for injections, as well as vitamin B6. Hainan Shuangcheng Pharmace… Read more